Cytoplasm-predominant Pten associates with increased region-specific brain tyrosine hydroxylase and dopamine D2 receptors in mouse model with autistic traits

[1]  J. Buxbaum,et al.  Genetics and genomics of autism spectrum disorder: embracing complexity. , 2015, Human molecular genetics.

[2]  Julien Séjourné,et al.  Pten Mutations Alter Brain Growth Trajectory and Allocation of Cell Types through Elevated β-Catenin Signaling , 2015, The Journal of Neuroscience.

[3]  John D. Eicher,et al.  Language Impairment and Dyslexia Genes Influence Language Skills in Children With Autism Spectrum Disorders , 2015, Autism research : official journal of the International Society for Autism Research.

[4]  N. Philip,et al.  Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome. , 2015, European journal of paediatric neurology.

[5]  A. Clipperton-Allen,et al.  Decreased aggression and increased repetitive behavior in Pten haploinsufficient mice , 2015, Genes, brain, and behavior.

[6]  J. Sutcliffe,et al.  Rare Autism-Associated Variants Implicate Syntaxin 1 (STX1 R26Q) Phosphorylation and the Dopamine Transporter (hDAT R51W) in Dopamine Neurotransmission and Behaviors , 2015, EBioMedicine.

[7]  J. Sutcliffe,et al.  SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking , 2014, Translational Psychiatry.

[8]  C. Eng,et al.  Molecular and Phenotypic Abnormalities in Individuals with Germline Heterozygous PTEN Mutations and Autism , 2014, Molecular Psychiatry.

[9]  C. Eng,et al.  Germline disruption of Pten localization causes enhanced sex-dependent social motivation and increased glial production. , 2014, Human molecular genetics.

[10]  Biliana Veleva-Rotse,et al.  Brain patterning perturbations following PTEN loss , 2014, Front. Mol. Neurosci..

[11]  R. Tancredi,et al.  Autism-epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening , 2014, BMC Medical Genetics.

[12]  A. Clipperton-Allen,et al.  Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autism-relevant behavioral tests. , 2014, Human molecular genetics.

[13]  J. Sutcliffe,et al.  De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder , 2013, Molecular Psychiatry.

[14]  A. Granholm,et al.  PTEN deletion enhances survival, neurite outgrowth and function of dopamine neuron grafts to MitoPark mice , 2012, Brain : a journal of neurology.

[15]  A. Hajnal,et al.  PTEN Negatively Regulates MAPK Signaling during Caenorhabditis elegans Vulval Development , 2012, PLoS genetics.

[16]  C. Schwartz,et al.  DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families , 2012, Behavioral and Brain Functions.

[17]  A. Schober,et al.  Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  W. Staal,et al.  Brief Report: The Dopamine-3-Receptor Gene (DRD3) is Associated with Specific Repetitive Behavior in Autism Spectrum Disorder (ASD) , 2011, Journal of autism and developmental disorders.

[19]  C. Eng,et al.  Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model , 2011, European Journal of Human Genetics.

[20]  Kandamurugu Manickam,et al.  Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly , 2010, Autism research : official journal of the International Society for Autism Research.

[21]  Qiuhao Qu,et al.  Neural stem cells in the developing and adult brains , 2009, Journal of cellular physiology.

[22]  A. Zapata,et al.  Selective Deletion of PTEN in Dopamine Neurons Leads to Trophic Effects and Adaptation of Striatal Medium Spiny Projecting Neurons , 2009, PloS one.

[23]  C. Eng,et al.  Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function , 2009, Human molecular genetics.

[24]  I. Bayazitov,et al.  Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities , 2008, Neuroscience.

[25]  J. Buitelaar,et al.  Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

[26]  C Eng,et al.  Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations , 2005, Journal of Medical Genetics.

[27]  L. Tsai,et al.  Cyclin-dependent Kinase 5 Phosphorylates Serine 31 of Tyrosine Hydroxylase and Regulates Its Stability* , 2004, Journal of Biological Chemistry.

[28]  M. Graham,et al.  Tyrosine hydroxylase phosphorylation: regulation and consequences , 2004, Journal of neurochemistry.

[29]  D. Pfaff,et al.  Inhibition of neuronal phenotype by PTEN in PC12 cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C Eng,et al.  PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model. , 2001, Human molecular genetics.

[31]  H. Wu,et al.  PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Montminy,et al.  CREB Is a Regulatory Target for the Protein Kinase Akt/PKB* , 1998, The Journal of Biological Chemistry.

[33]  R. Eeles,et al.  Germline PTEN mutations in Cowden syndrome-like families. , 1998, Journal of medical genetics.

[34]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.

[35]  P Kocsis,et al.  The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. , 1991, JAMA.

[36]  N. Bruneau,et al.  Urinary free and conjugated catecholamines and metabolites in autistic children , 1988, Journal of autism and developmental disorders.

[37]  J. Fermanian,et al.  Catecholamines metabolism in infantile autism: A controlled study of 22 autistic children , 1987, Journal of autism and developmental disorders.

[38]  辻井 正次,et al.  論文抄読 Brain Serotonin and Dopamine Transporter Bindings in Adults with High-Functioning Autism , 2010 .

[39]  Yasuomi Ouchi,et al.  Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. , 2010, Archives of general psychiatry.